IPO · Financials · Proposed listing on NYSE
Core Specialty IPO: how the business makes money
Core Specialty, a Cincinnati insurer, covers business risks that standard insurers often avoid. It wrote $4,566.5 million of gross premiums in FY2025 and earned net income of $118.9 million.
- Proposed ticker
- CORE
- Exchange
- NYSE
- Price range
- Not set
- Expected pricing
- Not stated
- Latest filing checked
- S-1 dated Nov 16, 2026
From the page's filings; page last updated .
By Hardik Bhandare · Checked against filings: . Editorial policy. Corrections
Follow Core Specialty
Email me when the price range is set or the IPO prices.
We'll send a confirmation email first. See our privacy policy.
Core Specialty Insurance Holdings, Inc. · Cincinnati, Ohio · Founded 2020
Based on the registration statement (Form S-1) dated .
Figures: from the preliminary prospectus (S-1), subject to change.
The company has publicly filed its registration statement (Form S-1 or F-1) with the SEC. No price range is set yet.
Last updated
- Total revenues, FY2025 (audited)
- $3,370.8M
- Net income to common stockholders, FY2025
- $96.5M
- Gross premiums written, FY2025
- $4,566.5M
- New shares sold by the company
- None
- Directors and management, Sep 30, 2026
- 13%
The short version
The Core Specialty IPO in 5 points
1 · What it sells
Core Specialty sells specialty insurance to businesses through 17 divisions, and wrote $4,566.5 million of gross premiums in FY2025.
2 · Who pays it
By FY2025 gross premiums written, the S-1 puts Specialty Casualty at 54%, Property & Short-tail at 37% and Bond, Credit & Guarantee at 9%.
3 · What it keeps from $100
Of every $100 of FY2025 total revenues, claims took $63.1, acquisition costs $18.6 and overhead $10.0, leaving $3.5 after tax and a $2.1 software write-off (Cityfort calculation from S-1 filed Nov 16, 2026).
4 · Where the operating profit comes from
Profit comes from underwriting and investing: the combined ratioAn insurer's claims plus underwriting costs, per $100 of premiums earned. Under 100% means premiums covered both. was 97.4% in FY2025, and net investment income was $176.5 million.
5 · The one thing to watch
Reinsurers took 44% of gross premiums written in the nine months to Sep 30, 2026, against 31% a year earlier.
Sources: From Core Specialty's S-1 filed Nov 16, 2026 · checked
Each week: the next company due to report earnings, explained in 5 points.
No tips. Unsubscribe anytime.
We'll send a confirmation email. See our privacy policy.
01The business in one line
What does Core Specialty do?
Core Specialty collects premiums from businesses for hard-to-place risks, passes part of them to reinsurers, and invests the money until claims are paid.
- Businesses pay premiums, mostly through brokers and agents, for cover such as hurricane-exposed property, truck fleets and professional mistakes.
- Of every $100 of FY2025 total revenues, claims took $63.1 and broker commissions and other acquisition costs $18.6; $3.5 was kept as net income (Cityfort calculation from S-1 filed Nov 16, 2026).
02The offer
What is the Core Specialty IPO?
- Shares sold by existing stockholders
- Not yet in the filing
- To list on
- NYSE
- Proposed ticker
- CORE
- Lock-up on existing holders
- 180 days
- Selling stockholders: the S-1 lists Corinthian DF Holdings, Cavello Bay Reinsurance, Aquiline Financial Services Fund IV, David P. Delaney Jr. and Timothy D. Delaney. It leaves the number of shares each sells blank.
- New shares: none. The S-1 says "We will not be selling any shares in this offering" and that the selling stockholders receive all the net proceeds.
- Purpose, as the S-1 states it: to create a public market for the stock, ease future access to public equity markets and raise the company's visibility.
- Underwriters' option: more shares within 30 days, all from the selling stockholders; the number is blank.
- Terms still blank in the S-1: price range, share counts, underwriting discount, settlement date and the stock split ratio. They usually appear in a later amendment (S-1/A).
- Underwriters: J.P. Morgan and Goldman Sachs lead, with BMO Capital Markets as a joint book-running manager. The stock is to trade on the NYSE as "CORE".
The company, its executive officers and directors, the selling stockholders and substantially all other stockholders agree not to sell for 180 days after the prospectus date. J.P. Morgan and Goldman Sachs can release them at their discretion.
Share classes and votes
- Directed share program
- The S-1 says a percentage of the shares, left blank, may be set aside for employees, certain directors and other parties. Directors and officers who buy them are bound by the 180-day lock-up.
- Lead underwriters
- J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC
- Transfer agent
- Not yet named in the S-1 filed Nov 16, 2026
Learn: How to read an S-1: Anthropic's IPO registration statement · IPO lock-up agreements: what they are and when they end
03Key dates
What are the key dates for the Core Specialty IPO?
| Event | Date | Source |
|---|---|---|
| Registration statement (S-1) filed | Core Specialty Insurance Holdings, Inc. Form S-1 (registration statement) | |
| Expected pricingNot yet stated in a filing. The S-1 leaves the price range and settlement date blank. | Not yet stated | Core Specialty Insurance Holdings, Inc. Form S-1 (registration statement) |
| Lock-up ends180 days after the prospectus date, which is not yet set. | Not yet stated | Core Specialty Insurance Holdings, Inc. Form S-1 (registration statement) |
Learn: IPO lock-up agreements: what they are and when they end · How to read an S-1: Anthropic's IPO registration statement
04What it sells
What does Core Specialty sell?
Property & Short-tail
Cover where claims are known quickly: hurricane- and quake-exposed property, crop reinsurance for farm insurers, show horses, marine and energy, and aviation. 37% of FY2025 gross premiums written, per the S-1.
Specialty Casualty
Liability cover where claims can take years: commercial auto for bus and truck fleets, directors and officers, professional errors, excess casualty, healthcare liability, workers' compensation and medical and dental excess cover for employers' health plans. 54% of FY2025 gross premiums written.
Bond, Credit & Guarantee
Credit-related cover for banks, car dealers and credit unions, reinsurance for government-sponsored mortgage enterprises, and bail and commercial surety bonds. 9% of FY2025 gross premiums written; it began in 2024.
What it does
- Does: Writes specialty commercial insurance through six insurance subsidiaries
- Does: Sells some policies on an excess and surplus (E&S) basis, where it has more freedom over rates and policy wording
- Does: Buys reinsurance to pass part of its risk, and part of its premium, to other insurers
- Does: Invests the premiums it holds until claims are paid
What it does not do
- Does not: Does not sell mainly direct: independent agents, retail and wholesale brokers, program administrators and managing general agents sell its policies
- Does not: Does not get any money from this offering; the selling stockholders do
- Does not: Says all its net reserves were written or acquired since 2020; a 2020 Enstar deal reinsured StarStone's liabilities for premium earned through Oct 31, 2020, per the S-1
05Who pays it
Who pays Core Specialty?
Core Specialty does not disclose how much each type of customer pays.
Businesses and institutions
Pay premiums for property, liability, auto, workers' compensation and other cover, mostly through brokers and agents.
Other insurers
Crop insurers and government-sponsored mortgage enterprises pay premiums to its Agriculture and Mortgage Reinsurance divisions for reinsurance.
Third-party insurers
Pay fees and commissions on policies Core Specialty places with them: $82.0 million in FY2025.
Customer concentration
By broker, not by customer: Amwins Group placed 19% of FY2025 gross premiums written and Marsh & McLennan 12% (29% and 17% in FY2023). In the nine months to Sep 30, 2026, Amwins, Marsh & McLennan and Stratus LLC placed 11%, 14% and 14%. Director Steve DeCarlo is Executive Chair of Amwins.
- Largest customer
- 19%
06How the money flows · FY2025
How does money flow through Core Specialty?
Money in
- Net premiums earned$3.1B
- Net investment income$177M
- Fees and commission income$82M
- Net realized and unrealized investment gains$39.5M
- Other income (part of total revenues)$0.1M
The company
Core Specialty
$3.4B came in
Money out
- Claims and claim expenses (net incurred losses and LAE)$2.1B
- Acquisition costs (broker commissions and similar)$626M
- General and administrative$338M
- Loss on abandoning software assets$72M
- Provision for legal settlement$25M
- Interest expense$21.7M
- Corporate and other expenses$10.8M
- Income tax$29.8M
- Net income$119M
- Businesses pay premiums for cover. Core Specialty keeps part and pays part to reinsurers, which take on that share of the risk. Gross premiums written were $4,566.5 million in FY2025, and net premiums earned $3,072.7 million.
- It invests the premiums until claims are paid. Net investment income was $176.5 million in FY2025, plus $39.5 million of investment gains.
- Claims and the cost of handling them took $2,128.1 million. Brokers' commissions and other acquisition costs took $626.3 million, and overhead $338.2 million.
- Two other items hit FY2025: a $72.0 million loss on abandoning software assets ($8.1 million in FY2024) and a $25.0 million provision for a legal settlement.
- After interest and $29.8 million of income tax, net income was $118.9 million. $96.5 million of it was attributable to common stockholders after preferred dividends.
07Where the money goes · FY2025
Where does $100 of Core Specialty's money go?
Core Specialty · FY2025
Receipt for every $100
| Claims and claim expenses | $63.1 |
|---|---|
| Acquisition costs | $18.6 |
| General and administrative | $10.0 |
| Software write-off | $2.1 |
| Interest, legal settlement and corporate costs | $1.7 |
| Income tax | $0.9 |
| Kept as net income | $3.5 |
| Total | $100 |
Each line = amount ÷ total money in × 100. Lines may not add to exactly $100 because of rounding.
How this is worked out
Cityfort calculation from S-1 filed Nov 16, 2026. Of every $100 of FY2025 total revenues ($3,370.8 million). Each line = line ÷ total revenues × 100, rounded, so lines may not add exactly to 100. Interest, the legal settlement and corporate costs are combined.
08What it needs to run
What does Core Specialty need to run?
Capital and a financial strength rating
Stockholders' equity was $1.4 billion at Sep 30, 2026. AM Best rates it "A" (Excellent); the company says a rating of "A-" or higher is important to compete in most of its lines.
Specialist underwriters
About 1,139 employees at Sep 30, 2026, organized into 17 divisions that make their own underwriting, distribution and claims decisions. Core Specialty has added 13 divisions since 2020.
Reinsurance
Reinsurers took 44% of gross premiums written in the nine months to Sep 30, 2026, up from 31% a year earlier. The S-1 says it retains $28.3 million of risk per property event and its property program covers up to $566 million.
Brokers and agents
Wholesale and retail brokers, agents and program administrators bring in the business; three wholesale brokers placed 39% of gross premiums written in the nine months to Sep 30, 2026.
One technology platform
A company-wide cloud-based underwriting and claims platform. It wrote off $72.0 million of abandoned software assets in FY2025.
09How it makes money
How does Core Specialty make money?
It earns when premiums cover claims and costs, and again on the money it invests before claims are paid.
The combined ratio is claims plus underwriting expenses per $100 of premiums earned; below 100% means underwriting made a profit. Core Specialty's was 97.4% in FY2025 and 93.0% in the nine months to Sep 30, 2026. Net investment income was $149.6 million in those nine months.
Combined ratio (claims and underwriting costs per $100 of premiums earned)
98.3%93.0%
FY2023 to Nine months ended Sep 30, 2026
- Specialist divisions price and write the risk
- Brokers and agents bring in the policy and the premium
- Pass part of the risk and premium to reinsurers
- Invest the premium while claims are reported and settled
- Pay claims; what is left is underwriting profit plus investment income
↺ Step 5 feeds back into step 1.
10Business segments · FY2025
Which businesses make up Core Specialty?
Property & Short-tail
36.4%Gross premiums written, not revenue. Underwriting profit $101.6 million; combined ratio 91.3%. Share of the total is a Cityfort calculation from S-1 filed Nov 16, 2026 (the S-1 shows 37%).
Revenue $1.7B ($1,662M)
Specialty Casualty
54.4%Gross premiums written. Underwriting loss $4.4 million; combined ratio 100.3%.
Revenue $2.5B ($2,482M)
Bond, Credit & Guarantee
9.3%Gross premiums written. Underwriting loss $17.2 million; combined ratio 104.5%. The segment began in 2024.
Revenue $423M
How the mix changed
- Property & Short-tail
- Specialty Casualty
- Bond, Credit & Guarantee
Revenue by segment, FY2023 to FY2025.
US$
See the numbers
11Competitors and what protects it
Who does Core Specialty compete with?
Kinsale Capital Group, Inc.
A specialty insurance carrier the S-1 names as a competitor.
Markel Group Inc.
A specialty insurance carrier the S-1 names as a competitor.
RLI Corp.
A specialty insurance carrier the S-1 names as a competitor.
Skyward Specialty Insurance Group, Inc.
A specialty insurance carrier the S-1 names as a competitor.
American International Group, Inc.
NYSE: AIG
A globally active insurer the S-1 names as a competitor, along with Berkshire Hathaway, CNA, The Hartford, Lloyd's of London and Travelers.
What protects the business
Each strength is scored 1 (weak) to 5 (strong) for the business, with the reason. It is not a rating of the share.
- Financial strength rating3 of 5
AM Best rates the group "A" (Excellent), with a "Strongest" capital adequacy score of 99.6; the company says "A-" or higher is important to compete in most lines.
- Spread across lines3 of 5
17 divisions in three segments; no segment was more than 54% of FY2025 gross premiums written.
- Protection on old reserves3 of 5
A 2020 loss portfolio transfer and adverse development cover (reinsurance that takes over old claims and pays if they grow) with Enstar reinsured the StarStone net liabilities for premium earned through Oct 31, 2020, with a limit of $130.0 million above the assumed reserves.
Weak spot
Reliance on a few brokers
Three wholesale brokers placed 39% of gross premiums written in the nine months to Sep 30, 2026. The S-1 says some brokers own insurers that compete with it and may favor them.
12The numbers · Consolidated · US$
How has Core Specialty done?
Revenue
$3.4BFY2025
Total revenues rose from $2,480.0 million in FY2023 to $3,370.8 million in FY2025. They were $2,157.5 million in the nine months to Sep 30, 2026 against $2,553.4 million a year earlier, as more premium went to reinsurers and net premiums earned fell to $2,036.6 million from $2,325.6 million.
US$
See the numbers
Net income
$96.5MFY2025
Net income attributable to common stockholders was $96.5 million in FY2025 (net income $118.9 million) and $68.8 million in the nine months to Sep 30, 2026, a period with $105.3 million of net realized and unrealized investment losses.
US$
See the numbers
Net income for every $100 of revenue
$2.9FY2025
Net income to common stockholders was $2.9 per $100 of FY2025 total revenues. EBITDA is left blank because the S-1 reports none. EPS is left blank because its share counts come before a stock split whose ratio is still blank.
Net margin: $ of net income per $100 of revenue
See the numbers
Free cash flow
$600MFY2025
Free cash flow (Cityfort calculation from S-1 filed Nov 16, 2026: operating cash flow minus purchases of fixed assets) was $599.7 million in FY2025 and $644.2 million in FY2024. An insurer's operating cash flow includes premiums collected before claims are paid.
US$ · cash from operations minus spending on plants and equipment
See the numbers
See all yearly numbers
EBITDA here = operating income plus depreciation and amortization (from the cash flow statement). Fiscal years are the company's own: December 31. Net income is the share belonging to the company's owners. Total net income differs from net profit to the company's owners: Net income before preferred dividends; netProfit is net income attributable to common stockholders.
Latest part-year · Nine months ended Sep 30, 2026 (9 months to Sep 30, 2026)
- Revenue
- $2.2B
- Net profit
- $68.8M
A part-year can't be compared with a full year. Audited figures from the S-1 (interim period unaudited), in US$ million.
Learn: Stock-based compensation and dilution: pay that becomes shares
13Financial strength · Sep 30, 2026
How much debt does Core Specialty have?
- Total debt$397M
- Cash and investments$262M
- Net debt (debt minus cash)$135M
- Net worth (shareholders' money)$1.4B
- Debt to equity
- 0.27×
- $ of debt for every $1 of shareholders' money
- Most of the debt is a $361.5 million revolving credit facility; the rest is $25.8 million of junior subordinated debentures and a $10.0 million surplus note. The capitalization table shows total debt of $397.3 million.
- The company reports debt including subordinated debentures and hybrids at 26.4% of adjusted capitalization at Sep 30, 2026, down from 29.1% at Dec 31, 2024.
- Stockholders' equity was $1,445.1 million. A further $165.0 million of Series A convertible preferred stock sits outside it and converts into common stock just before the offering. Debt to equity uses $1,445.1 million (Cityfort calculation from S-1 filed Nov 16, 2026).
- Insurance reserves for future claims were $4,805.3 million and unearned premiums $1,994.6 million, against investments of $4,366.8 million and $2,153.2 million recoverable from reinsurers.
- AM Best rates the insurance companies "A" (Excellent), except Standard Life and Accident at "A-", as of Dec 31, 2025.
14Who owns it before the IPO · Sep 30, 2026
Who owns Core Specialty before the IPO?
- Officers and directors (as a group), shares
- 13.0%
Largest stockholders before the IPO
From the prospectus table of principal stockholders. Holdings fall after the IPO when new shares are sold; the prospectus also shows the holding after the offering.
15Who runs it
Who runs Core Specialty, and did they deliver?
Joseph E. ("Jeff") Consolino
Founder, Chairman, President and Chief Executive Officer · since 2020
Director since the company's start. Previously Executive Vice President and CFO of American Financial Group (2013 to 2020). A director of Amwins since 2006.
Evan M. Cabat
Executive Vice President and Chief Financial Officer · since 2025
Joined in October 2025 from SiriusPoint, where he was Chief Accounting Officer.
Michael L. Powell
Executive Vice President and General Counsel · since 2026
Joined in May 2026 from Fifth Third Bank.
Jeffrey C. Wanamaker
Chief Underwriting Officer · since 2020
In the role since October 2020; previously at StarStone US.
Cathryn C. Warner
Chief Operating Officer · since 2020
In the role since December 2020, after the StarStone US acquisition.
16Governance signals
What do Core Specialty's governance filings show?
- Auditor
- Ernst & Young LLP, since 2021
- Auditor changes
- None in the period covered
- Audit qualifications
- None reported
- Related-party dealings
- The S-1 lists related-party dealings since Jan 1, 2023. They involve Enstar (reserve reinsurance and quota share covers, where a reinsurer takes a fixed share of premiums and claims); entities linked to director David P. Delaney Jr. (services and software); Gramercy, WM Phoenix and Proof Insurance Solutions (program business; the company holds investments in them); and Amwins, its largest broker, whose Executive Chair is a director.
- Credit rating
- Not checked for this page
Flags to know about
disclosure
Material weakness in internal control
The S-1 says one material weakness remains, related to data from third parties such as managing general agents and third-party administrators. Others found in the FY2024 audit were remediated, per the S-1.
related party
Largest broker linked to the board
Amwins placed 19% of FY2025 gross premiums written. Director Steve DeCarlo is its Executive Chair, and CEO Jeff Consolino and directors Matt Ebbel and Patrick Gordon sit on its board.
other
Board seats for pre-IPO investors
Under an Investor Rights Agreement effective just before the offering, Dragoneer and SkyKnight may appoint up to four directors, Enstar and the management stockholders two each, and Aquiline and the Delaney Group one each.
17Group and related parties
How much does Core Specialty rely on related parties?
- Enstar: a loss portfolio transfer and adverse development cover with Clarendon, an Enstar subsidiary guaranteed by Enstar, covers StarStone liabilities on premium earned through Oct 31, 2020. The company paid interest of $0.6 million to Cavello Bay in FY2025 under quota share covers.
- Delaney entities: income from a services agreement with LFG Capital Partners fell to $0.3 million in FY2025 from $9.4 million in FY2024. Granada Indemnity was paid $3.3 million for IT consulting in FY2025, and Quaker Project $0.7 million for software maintenance.
- Gramercy, in which the company holds preferred stock, produced $89.6 million of gross premiums written in FY2025, with $20.0 million of commission expense.
- WM Phoenix and Proof Insurance Solutions, in which it holds private equity investments, produced $32.3 million and $10.0 million of gross premiums written in FY2025.
- Amwins, the largest broker at 19% of FY2025 gross premiums written, has a Core Specialty director as Executive Chair.
18Legal cases · as of Nov 16, 2026
What legal cases does the Core Specialty offer document list?
Outstanding cases
Cases are listed as the offer document describes them. A pending case is an allegation until a court or regulator decides it.
19What could go wrong
What could go wrong for Core Specialty?
- Other
Catastrophes and severe weather
Hurricanes, earthquakes, other disasters and pandemics can cause large losses. The S-1 gives a preliminary $3 million to $5 million pre-tax loss estimate, net of reinsurance, for Hurricane Isaias in October 2026.
Watch Catastrophe losses in the fourth-quarter results and the combined ratio.
- Other
Reserves may prove too small
Loss reserves are estimates of claims not yet paid; gross loss and claim-expense reserves were $4.7 billion at Sep 30, 2026. Social inflation and new claim issues can raise costs, per the S-1.
Watch Prior-year reserve development reported in later filings.
- Concentration
Reliance on a few brokers
Amwins, Marsh & McLennan and Stratus placed 39% of gross premiums written in the nine months to Sep 30, 2026. Losing much of one broker's business could hurt results.
Watch The top brokers' share of gross premiums written.
- Other
Dependence on reinsurers
Reinsurers took 44% of gross premiums written in the nine months to Sep 30, 2026, against 31% a year earlier. Reinsurers may pay late or not at all, and cover may cost more or be unavailable.
Watch Ceded share of premiums and amounts recoverable from reinsurers ($2,153.2 million at Sep 30, 2026).
- Pricing
Insurance price cycle
Results swing with insurance cycles, "such as the current soft market", in the S-1's words. In a soft market, prices fall and capacity grows.
Watch Growth in gross premiums written and the expense ratio.
- Governance
Internal control weakness
One material weakness remains, around data from third parties such as managing general agents. The S-1 says it cannot assure it will remediate it.
Watch Whether later filings report the weakness remediated.
20Risks of the offer
What risks does the Core Specialty offer document flag?
No public market yet
The shares have never traded. The S-1 says an active market may not develop and the price may be volatile.
Sales by existing holders
Certain pre-IPO investors have registration rights. Sales after the 180-day lock-upA period after an IPO when insiders agree not to sell their shares. Learn more, or the expectation of them, could weigh on the price, per the S-1.
Company gets no money
All shares are sold by selling stockholders, so the offering adds no capital to the company.
Anti-takeover provisions
Changing certain charter provisions needs at least 75% of the voting power, which the S-1 says could delay or prevent a change of control.
Holding company relies on subsidiaries
The listed company depends on dividends from its insurance subsidiaries to pay dividends on its common stock, and the S-1 says minimum capital rules limit those subsidiary dividends.
Terms not set
The S-1 leaves the price range, number of shares and stock split ratio blank, so per-share figures will change.
21How it got here
How did Core Specialty get here?
2020
Milestone
Founded
Formed in 2020; in November it bought StarStone US Holdings from an Enstar subsidiary and North Bay Holdings.
2021
Milestone
Merged with Lancer
Merged with Lancer Financial Group, adding commercial auto insurance for bus and truck fleets.
2022
Milestone
Hallmark E&S operations
In October bought Hallmark Financial's excess and surplus lines operations, with about 178 employees and the renewal rights.
2023
Milestone
Employer health-plan cover added
In December bought American National Group's medical excess cover business for employers' health plans, including Standard Life and Accident Insurance Company.
2024
Milestone
Specialty Markets Group
In February completed the Specialty Markets Group transfer from American National; the Bond, Credit & Guarantee segment had its first significant activity this year.
2025
Crisis
Software write-off and legal provision
Recorded a $72.0 million loss on abandoning software assets and a $25.0 million provision for a bail bond class action.
2026
Milestone
Public S-1 filed
Filed its S-1 on Nov 16, 2026 for a proposed NYSE listing as "CORE".
22Supporters vs. critics
What do supporters and critics point to?
What supporters point to
- The combined ratio was 93.0% in the nine months to Sep 30, 2026, down from 98.3% in FY2023, so underwriting made a profit in both periods.
- Total revenues rose from $2,480.0 million in FY2023 to $3,370.8 million in FY2025.
- AM Best rates the insurance companies "A" (Excellent), except Standard Life and Accident at "A-", as of Dec 31, 2025.
- A 2020 reinsurance deal with Enstar covers the old StarStone net liabilities, with a limit of $130.0 million above the assumed reserves.
- Free cash flow was $599.7 million in FY2025 (Cityfort calculation from S-1 filed Nov 16, 2026), though an insurer's operating cash includes premiums held before claims are paid.
What critics point to
- Three wholesale brokers placed 39% of gross premiums written in the nine months to Sep 30, 2026; Amwins, the largest in FY2025 (19%), has a Core Specialty director as its Executive Chair.
- Net income to common stockholders fell to $96.5 million in FY2025 from $139.0 million in FY2024, after a $72.0 million software write-off and a $25.0 million legal provision.
- Net premiums earned fell to $2,036.6 million in the nine months to Sep 30, 2026 from $2,325.6 million, as more premium went to reinsurers.
- Specialty Casualty, 54% of FY2025 gross premiums written, had a combined ratio of 100.3%, an underwriting loss of $4.4 million.
- The S-1 says one material weakness in internal control remains, around data from third parties such as managing general agents.
23What to watch next
What should you watch next for Core Specialty?
Next event
S-1/A with a price range
Date not announced yet.
Price range and share counts
The S-1 of Nov 16, 2026 leaves the price range, shares offered and stock split ratio blank; a later amendment (S-1/A) usually states them.
Share of premiums passed to reinsurers
Reinsurers took 44% of gross premiums written in the nine months to Sep 30, 2026, against 31% a year earlier, which lowered net premiums earned.
Hurricane Isaias losses
The S-1 gives a preliminary $3 million to $5 million pre-tax loss estimate, net of reinsurance, for the October 2026 storm.
Broker concentration
Amwins, Marsh & McLennan and Stratus placed 39% of gross premiums written in the nine months to Sep 30, 2026.
Material weakness
Whether later filings report the remaining internal control weakness remediated.
Bail bond class action settlement
American Surety agreed on Feb 13, 2026 to settle for $15.2 million, subject to court approval. The S-1 says a preliminary approval hearing is scheduled by the end of 2026.
24Key facts
Key facts about Core Specialty
- When is the Core Specialty IPO date?
- Not yet stated in the S-1 dated Nov 16, 2026.
- What is the Core Specialty IPO price range?
- Not yet stated in the S-1 dated Nov 16, 2026.
- What ticker will Core Specialty use?
- The S-1 dated Nov 16, 2026 names the proposed ticker CORE on NYSE.
- What does Core Specialty do?
- Core Specialty Insurance Holdings, Inc., based in Cincinnati, Ohio, sells specialty insurance to businesses through 17 divisions in three segments, according to its S-1 filed Nov 16, 2026.
- How does Core Specialty make money?
- Core Specialty earns when premiums cover claims and costs, and on the premiums it invests. Its combined ratio was 97.4% in FY2025, and net investment income was $176.5 million.
- Who are Core Specialty's customers?
- Core Specialty's customers are businesses and some other insurers, reached mostly through brokers. Amwins placed 19% and Marsh & McLennan 12% of its FY2025 gross premiums written.
- How big is Core Specialty?
- Core Specialty's total revenues were $3,370.8 million in FY2025, up from $3,217.2 million in FY2024. Net income to common stockholders was $96.5 million, down from $139.0 million.
- Who owns Core Specialty before the IPO?
- At Sep 30, 2026, Corinthian DF Holdings held 43% of Core Specialty, Cavello Bay Reinsurance 20%, Aquiline 8% and directors and management 13%, per the S-1's rounded figures.
- Who gets the money from the Core Specialty IPO?
- The selling stockholders, not Core Specialty: its S-1 filed Nov 16, 2026 offers no new shares, and the share counts and price range are still blank.
25Sources and changes
Where every number on this page comes from
Sources (1 document)
- S1Core Specialty Insurance Holdings, Inc. Form S-1 (registration statement) · SEC EDGAR · Tier 1: company or exchange filing · Nov 16, 2026
Changes to this page (v1 · Nov 19, 2026)
- v1 · Nov 19, 2026First version, from the S-1 filed Nov 16, 2026. (first version, based on the S-1)
Numbers come only from tier 1 and tier 2 sources. Read how we research.
Disclaimer
For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.
Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a registered investment adviser or other qualified professional.
Cityfort, its owners and contributors may or may not hold securities of companies covered. Cityfort is not paid by any company it covers. Content is not an offer or solicitation to buy or sell any security, including in any initial public offering.
Read the positions policyRead the full disclaimerHide the full disclaimer
Cityfort publishes general educational content that explains how listed companies work. Cityfort is not registered with the US Securities and Exchange Commission or any state securities regulator as an investment adviser, and is not a broker-dealer or a member of FINRA. Cityfort does not provide investment, tax or legal advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security. Nothing on the site is tailored to any person's circumstances.
All information is taken from publicly available sources, mainly company filings with the SEC, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.
Statements by company management, including forward-looking statements and guidance, are reported as the company's statements, with their date and source; they are not our forecasts. Adjusted (non-GAAP) figures are the company's own measures and are shown next to the official (GAAP) figures.